US2485791A - Bone bank and method of preserving bones for transplantation - Google Patents
Bone bank and method of preserving bones for transplantation Download PDFInfo
- Publication number
- US2485791A US2485791A US32253A US3225348A US2485791A US 2485791 A US2485791 A US 2485791A US 32253 A US32253 A US 32253A US 3225348 A US3225348 A US 3225348A US 2485791 A US2485791 A US 2485791A
- Authority
- US
- United States
- Prior art keywords
- bones
- bone
- blood
- culture
- bank
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 210000000988 bone and bone Anatomy 0.000 title description 92
- 238000000034 method Methods 0.000 title description 9
- 238000002054 transplantation Methods 0.000 title description 9
- 210000004369 blood Anatomy 0.000 description 24
- 239000008280 blood Substances 0.000 description 23
- 238000012360 testing method Methods 0.000 description 12
- 210000002381 plasma Anatomy 0.000 description 10
- 210000002966 serum Anatomy 0.000 description 9
- JNMRHUJNCSQMMB-UHFFFAOYSA-N sulfathiazole Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CS1 JNMRHUJNCSQMMB-UHFFFAOYSA-N 0.000 description 6
- 229960001544 sulfathiazole Drugs 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 208000006379 syphilis Diseases 0.000 description 5
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 4
- 230000036760 body temperature Effects 0.000 description 4
- 230000017074 necrotic cell death Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000035899 viability Effects 0.000 description 4
- 206010003694 Atrophy Diseases 0.000 description 3
- 208000035473 Communicable disease Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 230000037444 atrophy Effects 0.000 description 3
- 238000011888 autopsy Methods 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 101150008122 Bcan gene Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000589970 Spirochaetales Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 238000005267 amalgamation Methods 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 238000009640 blood culture Methods 0.000 description 1
- 210000002449 bone cell Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000009940 knitting Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
Definitions
- This invention relates to..a method of. obtaining bones from living bodies or from recently expired bodies, and preserving such bones under conditions to maintain them viable for transplantation at later times into other living. bodies.
- the medical .pro profession has long considiered that autogenous bones are best adapted 'for grafting primarily because the blood. ce1l's-.of.
- Such'bones are of the same bloodtype as the.
- the viable and healthy bones obtained and classified by the above described methods are placed in vitro in prepared cultures of blood plasma of blood serum to which has been added a sufficient volume of anti-biotic substance, as sulfa-thiazole, to inhibit the growth of bacteria and other organisms therein.
- Plasma is essentially the liquid portion of the blood which has been separated without clotting, and contains in solution albumin, globulin, and fibrinogen.
- Serum is the liquid constituent of the blood remaining after coagulation, and as such has had separated therefrom those components of the blood which combine in the substance of blood clots.
- Both plasma and serum may be optionally selected as the culture media for sustaining in vitro bone cells of any blood type, since both these substances contain therein the nutritive constituents of the blood for maintaining the bones viable.
- the fact that neither plasma nor serum contain therein blood cell matter which differentiates blood as to types makes it possible to use either plasma or serum without consideration as to the types of blood from which these derivatives have been obtained.
- the bones and the blood culture may not necessarily be kept in vitro but substances other than glass may be employed for the containers; however, glass is especially suitable because of its durability, transparency, opposition to absorption, and because of the ease with which it can be sterilized when the contents thereof may be removed.
- the maintaining of the culture and bones at refrigerated temperatures serves to materally reduce the rate at which the bones derive nutriment from the culture, and thus the period during which a culture may nourish bones therein is materially extended.
- Mean temperatures of 46 degrees Fahrenheit are indicated as suitable for maintaining the bones at a reduced rate of absorption of nutriment and in a substantially refrigerated state, and a temperature range of degrees may be set on the refrigerative means in which the bank is kept. However, these temperatures are not critical except as they are near a lower limit at which the processes in bones and culture may be materially and adversely affected by further reduced temperatures.
- the transplantable character of bones maintained by this invention appears to be due in part to the fact that the plasma or serum medium in which the bones are kept partially absorbs the calcium and phosphorus from the bones, and thereby accomplishes in advance part of a step preceding the amalgamation of the bone to be grafted with the bone of the body.
- bones maintained by the steps of this invention are even more adaptable for transplanting than bones which are obtained from a donor or other source and immediately thereafter employed for transplantation.
- This invention is not limited in its scope to the elimination from the bank of only bones which could transmit syphilis or other communicable diseases, but it is further limited to the elimination of bones of any type and having any factors or characteristics which could adversely affect the bodies on which such bones might be grafted.
- the classification of bones by two Rh factors and four blood types also does not limit the multiples of sub-classes into which the bones of the bank may be subdivided, but this invention broadly considers further beneficial bases of classification and sub-classification which may be developed by medical research.
- this invention considers the provision of a bank of viable and pre-selected bones by obtaining such bones in a viable state and maintaining them in a culture to sustain their viability over indefinitely extended periods.
- a method of providing a viable bone of a desired Rh factor and blood type comprising the steps of, testing donors to eliminate the use of bones from those donors having diseases communicable by bone grafting, testing donors not thus eliminated to identify a donor of desired Rh factor and blood type, removing the desired bone from such donor, placing the bone in a container having therein a blood plasma culture containing sulfa-thiazole as an anti-biotic agent, maintaining the container contents at temperatures below normal body temperatures, testing the bone atv intervals to observe for indications of atrophy and necrosis, replenishing the culture when indicated, thereby indefinitely maintaining the bone viable for transplantation.
- a method of providing a viable bone of a desired Rh factor and blood type comprising the steps of, testing donors to eliminate the use of bones from those donors having syphilis communicable by bone grafting, testing the remaining donors not thus eliminated to identify a donor of desired Rh factor and blood type, removing the desired bone from such donor, placing the bone in a container having therein a blood plasma culture containing sulfa-thiazole as an anti-biotic agent, maintaining the container contents at temperatures substantially below normal body temperatures, testing the bone at intervals to observe for decreasing viability, replenishing the culture when indicated, thereby indefinitely maintaining the bone viable for transplantation.
- a method of providing a viable bone of a desired Rh factor and blood type comprising the steps of, testing donors to eliminate the use of bones from those donors having diseases communicable by bone grafting, testing the donors not thus eliminated to identify a donor of desired Rh factor and blood type, removing the desired bone from such donor, placing the bone into a container having therein a blood serum culture containing sulfa-thiazole as an anti-biotic agent, maintaining the container contents thereof at temperatures below normal body temperatures, testing the bone at intervals to observe for indications of atrophy and necrosis, and replenishing the culture when indicated, thereby indefinitely maintaining the bone viable for transplantation.
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Description
Patented Oct. 2 5, 1 949 BONE BANK AND METHOD OEPRESERVING BONE Sv .FQR TRANSPLANTATION.
Eli Jordan Tiicke'r','Jr., Houston, Te'ii.
No Drawing Application; J unell), 1948;
Serial N0. 32,253
4 Claims. (01:12pm
This invention relates to..a method of. obtaining bones from living bodies or from recently expired bodies, and preserving such bones under conditions to maintain them viable for transplantation at later times into other living. bodies.
It is an object of this .inventionto provide a bone supply or bone bank consisting of viable and transplantable .bones which are. classified as to blood'types.
It is'another objectof this invention to provide a bone bank of viable. and transplantable bones so selected as. to preclude the inclusion of any bones which might communicate. syphilis and other communicablediseases in transplantation.
It is also an. object of this invention. to provide a bone bank'of this class consisting of viable bones classified into Rh-positive. and Rh-negative groups, thereby providing against attempts to graft bones from bodies of one typeof Rh factor onto. bones in bodiesof an. opposite factor.
It is also an object of. this invention to .pro-. vide a bone bank of. transplantablebones. which are kept viable throughnutrition derivedfrom a culture of blood serum or plasma in whichthe bones are maintained.
It is yet another object. of this inventionto provide a bone bank of this class in. whichlthe bones are kept in cultures containinga sufficient volume of sulfa-thiazole or other antisbioticrsubstance to inhibit the growth of bacteria or other organisms therein.
It is also an object of this/invention to provide a bone bank of this class. in which the bones and culture are maintained .in. a substantially refrigerated state at such temperatures below normal body temperature as to effectively.;re-.
duce the rate of absorption by thebones of .nutri-. ment from the culture thereby materially length-.- ening the period during which a culture may. nourish without replenishment the bones .kept.
therein.
It is also an object of .this'inventionto provide a bone bank of this class. in which the culture. may be changed or replenished from timeto. timeto indefinitely prolong the preservation of bones therein.
Other and further objects of this invention will be apparent upon: considering the specifica.-.
tion herein set forth.
The medical .profession has long considiered that autogenous bones are best adapted 'for grafting primarily because the blood. ce1l's-.of.
such'bones are of the same bloodtype as the.
bones forming the bed of the graft.
2 c insures against adverse reactions. within the red blood cells of thebone portion tobe grafted. or witli'ii the bone portion. of the body forming the b' .7
Human bloodhas been separated by medical analysis'into" four types, 0, A, B, and AB, the basisof classification being whether or not successful transfusion can be carried out between these roups. It'has" been foundthat, for. purposes pr transfusion, blood of type. 6 can .be transfused into bodies or. t pes A, B, and whereas blood. of type ABbannot. be transfused intcr any other type. Also, whereas blood of types A and Bcan'notbe inter-transfused nor transfused into a type 0 bddy, both types can be transfused into type AB bodies. Such relations" apply' to the grafting of bones as well as tor transfusions, and rris'neces'sary to know what type of bone is to be grafted into: what type of pew-wherever homologous bones are not avail! able?" Ithas also beendetermined' by the profession that humanbei'rrgs'have" in the blood certain other factors which oppose the transfusion and intermingling between bloods of opposite types and' for-pur p'oses of classification s'uch"fact'ors are-termed"Rlirpositive and Rh-negative factors. The incompatibilitybf these factors is most apparent'inoperations' where it is endeavored to graft bones from bodies-having blood or brie Rh factor onto" bones in bodieshaving blood of the opposite Rh factors. In such cases unfavorable reaotions re'sult which oppose. the knitting: together -01 the" bones" to be 'inter grafte'd.
The bonesupply-contemplated by this invena larger bone portionsamputatedfrom living pe'r-* son'sg'as Whl'la wholeueg may hav'e'to' be 'am' putated' as the result of a wreck or accident, in
I which-c'ase-the-victim may contribute the usable and unfractured portions-to the bone-bank. In
every" case the' most careful ste'riletechnique must-be-employed. in r'en'io'vi'n g the bones-donatedfrom-any source of bone: supply? The source of autopsy should be the-best source;
and could: be'developed by educating public concepts thereofi :in view of the? humanitarianzresults' to. be obtained When-autopsies .are granted; practically. all of. the bones? of. the expired-personmatn be. obtained-for the-bone bank, andthe-iact' Th'is'55 that the donors may have expired of certain diseases rather than by accident does not ordinarily lessen the value of the bones contributed. It is only necessary that the bones be healthy and that they be obtained promptly after respiration ceases, while the bones are still viable and before necrosis sets in.
However, in both the cases of donated amputated bones, and bones obtained by autopsy, it is necessary to test the bodies of the donors to eliminate obtaining donations from bodies having certain communicable diseases, particularly syphilis which is carried in the blood stream. This is necessary since the conditions under which the. bones are maintained in the bank, to be hereinafter described, could not with certainty exterminate the germs of these certain diseases, as
the spirochete of syphilis without possibly also.
affecting the viability of the bones.
The viable and healthy bones obtained and classified by the above described methods are placed in vitro in prepared cultures of blood plasma of blood serum to which has been added a sufficient volume of anti-biotic substance, as sulfa-thiazole, to inhibit the growth of bacteria and other organisms therein.
Plasma is essentially the liquid portion of the blood which has been separated without clotting, and contains in solution albumin, globulin, and fibrinogen. Serum, on the other hand, is the liquid constituent of the blood remaining after coagulation, and as such has had separated therefrom those components of the blood which combine in the substance of blood clots. Both plasma and serum may be optionally selected as the culture media for sustaining in vitro bone cells of any blood type, since both these substances contain therein the nutritive constituents of the blood for maintaining the bones viable. The fact that neither plasma nor serum contain therein blood cell matter which differentiates blood as to types makes it possible to use either plasma or serum without consideration as to the types of blood from which these derivatives have been obtained.
The bones and the blood culture may not necessarily be kept in vitro but substances other than glass may be employed for the containers; however, glass is especially suitable because of its durability, transparency, opposition to absorption, and because of the ease with which it can be sterilized when the contents thereof may be removed.
, The maintaining of the culture and bones at refrigerated temperatures serves to materally reduce the rate at which the bones derive nutriment from the culture, and thus the period during which a culture may nourish bones therein is materially extended.
Mean temperatures of 46 degrees Fahrenheit are indicated as suitable for maintaining the bones at a reduced rate of absorption of nutriment and in a substantially refrigerated state, and a temperature range of degrees may be set on the refrigerative means in which the bank is kept. However, these temperatures are not critical except as they are near a lower limit at which the processes in bones and culture may be materially and adversely affected by further reduced temperatures.
Microscopic tests, taken of the bones in the bank at necessary intervals will reveal if they have begun to atrophy or will show whether or not necrosis may haveset in. Upon the slightest indication of either of these symptoms the culture may be replenished with fresh ingredients of proper amounts of sulfa-thiazole, and of either plasma or serum. It also may be preferable to completely replace a culture partially depleted of nutriment by an entirely new culture and such may be done promptly without adversely affecting the existing viability of the bones in the bank.
The transplantable character of bones maintained by this invention appears to be due in part to the fact that the plasma or serum medium in which the bones are kept partially absorbs the calcium and phosphorus from the bones, and thereby accomplishes in advance part of a step preceding the amalgamation of the bone to be grafted with the bone of the body. Thus it can be seen that bones maintained by the steps of this invention are even more adaptable for transplanting than bones which are obtained from a donor or other source and immediately thereafter employed for transplantation.
This invention is not limited in its scope to the elimination from the bank of only bones which could transmit syphilis or other communicable diseases, but it is further limited to the elimination of bones of any type and having any factors or characteristics which could adversely affect the bodies on which such bones might be grafted.
The classification of bones by two Rh factors and four blood types also does not limit the multiples of sub-classes into which the bones of the bank may be subdivided, but this invention broadly considers further beneficial bases of classification and sub-classification which may be developed by medical research.
Broadly, this invention considers the provision of a bank of viable and pre-selected bones by obtaining such bones in a viable state and maintaining them in a culture to sustain their viability over indefinitely extended periods.
What is claimed is:
1. A method of providing a viable bone of a desired Rh factor and blood type comprising the steps of, testing donors to eliminate the use of bones from those donors having diseases communicable by bone grafting, testing donors not thus eliminated to identify a donor of desired Rh factor and blood type, removing the desired bone from such donor, placing the bone in a container having therein a blood plasma culture containing sulfa-thiazole as an anti-biotic agent, maintaining the container contents at temperatures below normal body temperatures, testing the bone atv intervals to observe for indications of atrophy and necrosis, replenishing the culture when indicated, thereby indefinitely maintaining the bone viable for transplantation.
2. A method of providing a viable bone of a desired Rh factor and blood type comprising the steps of, testing donors to eliminate the use of bones from those donors having syphilis communicable by bone grafting, testing the remaining donors not thus eliminated to identify a donor of desired Rh factor and blood type, removing the desired bone from such donor, placing the bone in a container having therein a blood plasma culture containing sulfa-thiazole as an anti-biotic agent, maintaining the container contents at temperatures substantially below normal body temperatures, testing the bone at intervals to observe for decreasing viability, replenishing the culture when indicated, thereby indefinitely maintaining the bone viable for transplantation.
3. A method of providing a viable bone of a desired Rh factor and blood type comprising the steps of, testing donors to eliminate the use of bones from those donors having diseases communicable by bone grafting, testing the donors not thus eliminated to identify a donor of desired Rh factor and blood type, removing the desired bone from such donor, placing the bone into a container having therein a blood serum culture containing sulfa-thiazole as an anti-biotic agent, maintaining the container contents thereof at temperatures below normal body temperatures, testing the bone at intervals to observe for indications of atrophy and necrosis, and replenishing the culture when indicated, thereby indefinitely maintaining the bone viable for transplantation.
4. A method of maintaining a bone or segment thereof in viable state for transplantation, which comprises testing donors to eliminate the use of bones from those having diseases communicable REFERENCES CITED The following references are of record in the file of this patent:
American Druggist for January 1948, pp. '72- 73, 112, 114, 116 and 118.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32253A US2485791A (en) | 1948-06-10 | 1948-06-10 | Bone bank and method of preserving bones for transplantation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32253A US2485791A (en) | 1948-06-10 | 1948-06-10 | Bone bank and method of preserving bones for transplantation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US2485791A true US2485791A (en) | 1949-10-25 |
Family
ID=21863925
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US32253A Expired - Lifetime US2485791A (en) | 1948-06-10 | 1948-06-10 | Bone bank and method of preserving bones for transplantation |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US2485791A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2621145A (en) * | 1949-08-17 | 1952-12-09 | Machteld E Sano | Bone mat compositions |
| US3022783A (en) * | 1962-02-27 | Method of preserving tissue such | ||
| US3126884A (en) * | 1964-03-31 | Method of preserving animal tissue | ||
| US3468136A (en) * | 1964-08-25 | 1969-09-23 | Emil S Swenson | Method for maintaining organs in a completely viable state |
-
1948
- 1948-06-10 US US32253A patent/US2485791A/en not_active Expired - Lifetime
Non-Patent Citations (1)
| Title |
|---|
| None * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3022783A (en) * | 1962-02-27 | Method of preserving tissue such | ||
| US3126884A (en) * | 1964-03-31 | Method of preserving animal tissue | ||
| US2621145A (en) * | 1949-08-17 | 1952-12-09 | Machteld E Sano | Bone mat compositions |
| US3468136A (en) * | 1964-08-25 | 1969-09-23 | Emil S Swenson | Method for maintaining organs in a completely viable state |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3303662A (en) | Process for cell preservation | |
| US6277557B1 (en) | Infusible grade short-term cell storage medium | |
| Moroff et al. | Concepts about current conditions for the preparation and storage of platelets | |
| Stiff et al. | Unfractionated human marrow cell cryopreservation using dimethylsulfoxide and hydroxyethyl starch | |
| Pegg | Long-term preservation of cells and tissues: a review | |
| US4473552A (en) | Anaerobic method for preserving whole blood, tissue and components containing living mammalian cells | |
| Hogge et al. | Platelet storage for 7 days in second‐generation blood bags | |
| Brune et al. | Efficacy, recovery, and safety of RBCs from autologous placental blood: clinical experience in 52 newborns | |
| US6790603B2 (en) | Compositions for the storage of platelets | |
| CN120036303A (en) | Cell freezing solution and application thereof | |
| Hubel et al. | Liquid storage, shipment, and cryopreservation of cord blood | |
| US2485791A (en) | Bone bank and method of preserving bones for transplantation | |
| Owens et al. | Cryopreserved platelets have decreased adhesive capacity | |
| Birkeland | The influence of different freezing procedures and different cryoprotective agents on the immunological capacity of frozen-stored lymphocytes | |
| Evans et al. | Recovery from liquid-nitrogen temperature of established cell lines frozen in chemically defined medium | |
| EP0061277B1 (en) | Anaerobic method for preserving whole blood, tissue and components containing living mammalian cells | |
| BCSH Blood Transfusion Task Force et al. | Guidelines for the collection, processing and storage of human bone marrow and peripheral stem cells for transplantation | |
| Rathbun et al. | Posttransfusion survival of red cells frozen for 8 weeks after 42‐day liquid storage in AS‐3 | |
| US20040229205A1 (en) | Compositions for the storage of platelets | |
| Fontaine et al. | Perioperative platelet Transfusion: not all platelet products are created equal | |
| Draman et al. | A preliminary study on coagulation parameters and sterility of thawed refrozen fresh frozen plasma | |
| RU2263448C1 (en) | Method of cryopreservation of umbilical blood | |
| RU2799019C1 (en) | Method of storage of non-cryopreserved autologous hematopoietic stem cells from peripheral blood | |
| Ziegler et al. | The prothrombin changes in banked blood | |
| Gerota et al. | Concentration of bone marrow stem cells using the Haemonetics system |